SS Innovations International Inc (SSII)
4.00
+0.80
(+25.00%)
USD |
OTCM |
Jun 25, 15:38
SS Innovations International Research and Development Expense (Quarterly): 0.073M for Dec. 31, 2022
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.073M |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.001M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.001M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.002M |
| December 31, 2019 | 0.0045M |
| September 30, 2019 | 0.0045M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0278M |
| March 31, 2019 | 0.0241M |
| December 31, 2018 | 0.0082M |
| September 30, 2018 | 0.0027M |
| June 30, 2018 | 0.0042M |
| March 31, 2018 | 0.0121M |
| December 31, 2017 | 0.014M |
| September 30, 2017 | 0.0061M |
| June 30, 2017 | 0.0046M |
| March 31, 2017 | 0.0465M |
| December 31, 2016 | 0.0459M |
| September 30, 2016 | 0.0544M |
| June 30, 2016 | 0.0272M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
0.073M
Maximum
Dec 2022
0.0081M
Average
0.0005M
Median
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 7.452M |
| Retractable Technologies Inc | 0.1423M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |